Ferdinand C. Breedveld

Author

Also Known As

Breedveld, F.C., FERDINAND C. BREEDVELD, Ferdinand Breedveld, Ferdinand C Breedveld, Ferdinand C Breedveld,, Ferdinand C. Breedveld

225

Publications

33.8K

Citations

H-Index

102

Concepts

All Affiliations

Leiden University Medical Center Leiden University Amsterdam UMC Location University of Amsterdam University of Leeds Medical University of Vienna

About

Ferdinand C. Breedveld is an author at Leiden University Medical Center specializing in medicine, rheumatoid arthritis, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	50	6.6K
2	Allergy	6	6	591
3	Public Health	4	4	307
4	Health Sciences	3	3	221
5	Natural Sciences	1	1	32

Ferdinand C. Breedveld

140

Publications

28.6K

Citations

H-Index

Page 1

	Year	Citations
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, New England Journal of Medicine	2000	3K
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, The Lancet InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease	1999	2.3K
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Arthritis & Rheumatism	2005	1.8K
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Annals of the Rheumatic Diseases	2013	1.8K
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Arthritis & Rheumatism	1998	1.6K
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Gerard A. Schellekens, Hendrik Visser, B.A.W. de Jong, Arthritis & Rheumatism	2000	1.4K
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial Paul Emery, Ferdinand C. Breedveld, Stephen Hall, The Lancet Rheumatoid DisorderRheumatologyMedicineRheumatic DiseasesParallel Treatment Trial	2008	813
How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis Henk Visser, Saskia le Cessie, Koen Vos, Arthritis & Rheumatism	2002	736
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteins T. Huizinga, Christopher I. Amos, Annette H M van der Helm–van Mil, Arthritis & Rheumatism	2005	585
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo Joel M. Kremer, Bradley J. Bloom, Ferdinand C. Breedveld, Arthritis & Rheumatism	2009	541

Page 1